Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2009

01-08-2009 | Original Article

Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome

A 10-year descriptive analysis

Authors: Sofiene Rekik, Imen Trabelsi, Mourad Hentati, Adnene Hammami, Mounir Ben Jemaa, Jamil Hachicha, Samir Kammoun

Published in: Clinical and Experimental Nephrology | Issue 4/2009

Login to get access

Abstract

Background

Infective endocarditis (IE) is a dreaded complication in hemodialysis (HD) patients and is strongly associated with morbidity and mortality.

Objectives

Our aim was to investigate clinical and echocardiographic characteristics, microbiological profile, management and outcome of patients on HD in a Tunisian (Tunisia, North Africa) high-volume tertiary-care centre.

Methods

Among 182 patients who fulfilled the modified Duke criteria for infective endocarditis between January 1997 and December 2006, 16 were on chronic HD and were included in the study.

Results

Mean age was 52.5 ± 22.3 years, ten were male and arteriovenous fistulas were the most commonly used access sites (12 out of 16 cases). Average duration of dialysis was 27.3 ± 30 months. Major causative organisms were Staphylococcus species (including methicillin-resistant Staphylococcus aureus) in 11 (68.7%) of the 16 cases. The mitral valve was the most commonly affected [9 patients out of 16 (56.2%)], followed by aortic valve in 4 cases (25.0%) and tricuspid valve in 1 case (6.2%). Complications were frequent, including congestive heart failure (56.2%), secondary septic localisations (31.2%), arterial emboli (18.7%), and cerebral haemorrhage (6.2%). Five patients underwent surgery and seven died during hospitalization (43.7% mortality rate). No recurrences of IE were recorded in the nine survivors after average 21.7 ± 17.3 months follow-up.

Conclusion

In this largest reported confirmed IE series in dialysis patients in a developing country, mortality was very high; mitral valve was the most commonly affected valve. Staphylococcus species were the major causative organisms.
Literature
1.
go back to reference McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc. 2000;75:1008–14.CrossRefPubMed McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc. 2000;75:1008–14.CrossRefPubMed
2.
go back to reference Maraj S, Jacobs LE, Kung SC, Raja R, Krishnasamy P, Maraj R, et al. Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci. 2002;324:254–60.CrossRefPubMed Maraj S, Jacobs LE, Kung SC, Raja R, Krishnasamy P, Maraj R, et al. Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci. 2002;324:254–60.CrossRefPubMed
3.
go back to reference Abbott KC, Agodoa LY. Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron. 2002;91:203–9.CrossRefPubMed Abbott KC, Agodoa LY. Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron. 2002;91:203–9.CrossRefPubMed
4.
5.
go back to reference Durack DT, Lukes AS, Bright DK. Duke endocarditis service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200–9.CrossRefPubMed Durack DT, Lukes AS, Bright DK. Duke endocarditis service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200–9.CrossRefPubMed
6.
go back to reference Kamalakannan K, Manohara R, Johnson LB, Gardin JM, Saravolatz LD. Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. Ann Thorac Surg. 2007;83:2081–6.CrossRefPubMed Kamalakannan K, Manohara R, Johnson LB, Gardin JM, Saravolatz LD. Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. Ann Thorac Surg. 2007;83:2081–6.CrossRefPubMed
7.
go back to reference Doulton T, Sabharwal N, Cairns HS, Schelenz S, Eykyn S, O’Donnell P, et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int. 2003;64:720–7.CrossRefPubMed Doulton T, Sabharwal N, Cairns HS, Schelenz S, Eykyn S, O’Donnell P, et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int. 2003;64:720–7.CrossRefPubMed
8.
go back to reference Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant. 2006;21:2184–90.CrossRefPubMed Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant. 2006;21:2184–90.CrossRefPubMed
9.
go back to reference Spies C, Madison JR, Schatz IJ. Infective endocarditis in patients with end-stage renal disease. Arch Intern Med. 2004;164:71–5.CrossRefPubMed Spies C, Madison JR, Schatz IJ. Infective endocarditis in patients with end-stage renal disease. Arch Intern Med. 2004;164:71–5.CrossRefPubMed
10.
go back to reference Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J. 1992;67:236–9.CrossRefPubMedPubMedCentral Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J. 1992;67:236–9.CrossRefPubMedPubMedCentral
11.
go back to reference Trabelsi I, Rekik S, Znazen A, Maaloul I, Abid D, Maalej A, et al. Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). Am J Cardiol. 2008;102:1247–51.CrossRefPubMed Trabelsi I, Rekik S, Znazen A, Maaloul I, Abid D, Maalej A, et al. Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). Am J Cardiol. 2008;102:1247–51.CrossRefPubMed
12.
go back to reference Leonard A, Leopoldo R, Shapiro FL. Bacterial endocarditis in regularly dialysed patients. Kidney Int. 1973;4:407–22.CrossRefPubMed Leonard A, Leopoldo R, Shapiro FL. Bacterial endocarditis in regularly dialysed patients. Kidney Int. 1973;4:407–22.CrossRefPubMed
13.
go back to reference Shroff GR, Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis. 2004;44:1077–82.CrossRefPubMed Shroff GR, Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis. 2004;44:1077–82.CrossRefPubMed
14.
go back to reference Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int. 1999;55:1081–109.CrossRefPubMed Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int. 1999;55:1081–109.CrossRefPubMed
15.
go back to reference Nucifora G, Badano LP, Viale P, Gianfagna P, Allocca G, Montanaro D, et al. Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J. 2007;28:2307–12.CrossRefPubMed Nucifora G, Badano LP, Viale P, Gianfagna P, Allocca G, Montanaro D, et al. Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J. 2007;28:2307–12.CrossRefPubMed
Metadata
Title
Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome
A 10-year descriptive analysis
Authors
Sofiene Rekik
Imen Trabelsi
Mourad Hentati
Adnene Hammami
Mounir Ben Jemaa
Jamil Hachicha
Samir Kammoun
Publication date
01-08-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0172-8

Other articles of this Issue 4/2009

Clinical and Experimental Nephrology 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.